Dr. Jafaru Abu

Consultant Gynecological Oncology Surgery at Burjeel Medical City.

Experience:

20 years

Areas of Expertise and Treatment

All diagnosed or suspected gynecological cancers

Ovarian masses
Postmenopausal bleeding
Abnormal uterine bleeding
Abnormal PAP smears
Suspicious vulvar lesions
Suspicious cervical lesions
Cervical abnormalities
Cervical cancers
Uterine or womb cancers
Ovarian cancer
Vaginal cancers
Vulvar cancers
Post coital bleeding
Irregular menstrual bleeding
Uterine fibroids
Keyhole hysterectomy (laparoscopic or robot assisted)
Abdominal hysterectomy
Cytoreductive surgery (ultraradical surgery) for advanced stages of ovarian cancer
Pelvic and para-aortic lymphadenectomy (open/laparoscopic/robotic)
Radical hysterectomy (open/laparoscopic/robotic)
Pelvic exenterate surgery for locally recurrent gynecological cancers
Colposcopy
Hysteroscopy
Myomectomy (open/laparoscopic/robotic)
Vaginectomy (open/laparoscopic/robotic)
Fertility preservation surgery for cervical cancer (trachelectomy – simple or radical)
Laparoscopic cervical cerclage
Ovarian transposition procedures (laparoscopic or robotic)
Sentinel lymph nodes for cervical and endometrial cancers (laparoscopic or robotic
Sentinel lymph nodes for vulvar cancer
Vulvectomy (radical or simple)
Groin nodes dissection

Education

MBBS from the University of Benin Medical School, Nigeria

MRCOG and FRCOG – postgraduate medical training and qualified as a Member (and later a Fellow) of the Royal College of Obstetricians and Gynecologists, UK

BSCCP – colposcopy accreditation from the British Society for Colposcopy and Cervical Pathology of the Royal College of Obstetricians and Gynecologists, UK

Master’s degree in clinical sciences from the University of Leicester, United Kingdom and earned double qualifications during his Specialist training years initially in Obstetrics and Gynecology and later in Gynecological Oncology: the Certificate of Completion of Specialist Training (CCST) in obstetrics and gynecology from the Royal College of Obstetricians and Gynecologists, UK, and the Certificate of Completion of Sub-specialty Training (CCST) in Gynecological Oncology, jointly from the Postgraduate Medical Education and Training Board (PMETB) and the Royal College of Obstetricians and Gynecologists, UK

Professional memberships:

Royal College of Obstetricians and Gynecologists (RCOG)
British Society for Colposcopy and Cervical Pathology (BSCCP)
British Gynecological Cancer Society (BGCS)
Formerly a Member of the Subspecialty Training Council of the BGCS
International Gynecological Cancer Society (IGCS)
European Society of Gynecological Oncologists (ESGO)
European Society of Gynecological Endoscopists (ESGE)
British and Irish Association of Robotic Gynecologists (BIARGS)
British Medical Association (BMA)
Medical Staffing Research Committee, Nottingham University Hospital (MSRC)

Research & Publications:

Outcome following trachelectomy procedures (fertility preservation for early stages of cervical cancer): BGCS 7-8 July 2022
Morbidity outcome following extensive ovarian cancer cytoreductive surgery at Nottingham University Hospitals, UK: BGCS 7-8 July 2022
Lipidomic Biomarkers in Polycystic Ovary Syndrome and Endometrial Cancer. International Journal of Molecular Sciences. 2020
An Unusual case of abdominal pain and weight loss – Clinical Vignette. Rheumatology. 2020
Sterol regulatory element binding protein-1 (SREBP1) gene expression is similarly increased in polycystic ovary syndrome and endometrial cancer. Acta Obstetrica Et Gynecologica Scandinavica. 2017
Up-regulation of genes involved in the insulin signaling pathway (IGF1, PTEN and IGFBP1) in the endometrium may link polycystic ovarian syndrome and endometrial cancer. Mol Cell Endocrinol 2016